- Oncology in Clinical Practice
- Search Author Details
Author Details
Czartoryska-Arłukowicz, Bogumiła
-
Vol 7, Supp. C (2011) - CASE REPORT
Molekularnie ukierunkowana terapia pacjentki z jasnokomórkowym rakiem nerki
Abstract PDF (Polish) -
Vol 7, No 4 (2011) - REVIEW ARTICLES
The therapy interfering EGFR activation in breast cancer patients
Abstract PDF (Polish) -
Vol 7, Supp. A (2011) - CASE REPORT
Chora z rozsianym rakiem piersi z nadekspresją HER2 leczona lapatynibem z kapecytabiną po progresji w trakcie leczenia trastuzumabem
Details PDF (Polish) -
Vol 7, Supp. D (2011) - CASE REPORT
Lapatynib z kapecytabiną w leczeniu chorej na raka piersi z przerzutami do ośrodkowego układu nerwowego
Details -
Vol 7, Supp. C (2011) - CASE REPORT
Leki molekularnie ukierunkowane w terapii raka jasnokomórkowego
Abstract PDF (Polish) -
Vol 9, No 3 (2013) - REVIEW ARTICLES
Significance of cooperation between pathomorphologist and oncologist in the treatment of gastrointestinal stromal tumors (GIST)
Abstract PDF (Polish) -
Vol 10, No 6 (2014) - CASE REPORTS
Durable response to fulvestrant therapy in a hormone receptor-positive metastatic breast cancer patient with massive metastatic disease
Abstract PDF (Polish) -
Vol 12, No 1 (2016) - REVIEW ARTICLES
The role of anthracyclines and dose dense therapy in an adjuvant setting, in HER2-positive early breast cancer, in clinical practice
Abstract PDF HTML -
Vol 11, Supp. G (2015) - CASE REPORT
Durable disease stabilization associated with octreotide LAR treatment in a patient with metastatic carcinoid of the small intestine
Abstract PDF (Polish) -
Ahead of print - ORIGINAL ARTICLES
Systemic treatment of patients with advanced pancreatic cancer — is there still a place for gemcitabine in the first-line setting? Experience of Polish oncology centers
Abstract PDF -
Ahead of print - ORIGINAL ARTICLES
Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index as clinical predictive and prognostic markers in patients with advanced pancreatic cancer receiving gemcitabine monotherapy
Abstract PDF
Important: This website uses cookies. More >>
The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.
Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl